Cabaletta Bio CEO to Speak at Stifel 2024 Virtual Cell Therapy Forum
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) announced that Steven Nichtberger, M.D., its Chief Executive Officer, will participate in a fireside chat at the Stifel 2024 Virtual Cell Therapy …
Cabaletta Bio CEO to Speak at Stifel 2024 Virtual Cell Therapy Forum Read More